Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhousheng Xiao

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Reviews in Endocrine & Metabolic Disorders|June 4, 2015
Physiological mechanisms and therapeutic potential of bone mechanosensingZhousheng Xiao, Leigh Darryl Quarles
Journal of Cellular Biochemistry|October 29, 2011
Downregulation of PKD1 by shRNA results in defective osteogenic differentiation via cAMP/PKA pathway in human MG-63 cellsNi Qiu, Honghao Zhou, Zhousheng Xiao
The Journal of Biological Chemistry|March 11, 2015
Membrane and integrative nuclear fibroblastic growth factor receptor (FGFR) regulation of FGF-23Xiaobin Han, Zhousheng Xiao, L Darryl Quarles
The Journal of Biological Chemistry|August 16, 2015
Membrane and integrative nuclear fibroblastic growth factor receptor (FGFR) regulation of FGF-23Xiaobin Han, Zhousheng Xiao, L Darryl Quarles
Current Medicinal Chemistry|April 1, 2020
Osteoporosis: Mechanism, Molecular Target and Current Status on Drug DevelopmentHanxuan Li, Zhousheng Xiao, L Darryl Quarles, et al.
Journal of Molecular and Cellular Cardiology|November 24, 2019
FGF23 induced left ventricular hypertrophy mediated by FGFR4 signaling in the myocardium is attenuated by soluble Klotho in miceXiaobin Han, Chun Cai, Zhousheng Xiao, et al.
Frontiers in Endocrinology|June 28, 2018
Role of Fibroblast Growth Factor-23 in Innate Immune ResponsesElizabeth A Fitzpatrick, Xiaobin Han, Zhousheng Xiao, et al.
Trends in Pharmacological Sciences|October 1, 2023
Structural asymmetry in FGF23 signalingShih-Hsien Liu, Zhousheng Xiao, Jeremy C Smith, et al.
Plos One|October 3, 2012
Conditional mesenchymal disruption of pkd1 results in osteopenia and polycystic kidney diseaseNi Qiu, Zhousheng Xiao, Li Cao, et al.
Plos One|December 15, 2010
Kif3a deficiency reverses the skeletal abnormalities in Pkd1 deficient mice by restoring the balance between osteogenesis and adipogenesisNi Qiu, Li Cao, Valentin David, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Reviews in Endocrine & Metabolic Disorders|June 4, 2015
Physiological mechanisms and therapeutic potential of bone mechanosensingZhousheng Xiao, Leigh Darryl Quarles
Journal of Cellular Biochemistry|October 29, 2011
Downregulation of PKD1 by shRNA results in defective osteogenic differentiation via cAMP/PKA pathway in human MG-63 cellsNi Qiu, Honghao Zhou, Zhousheng Xiao
The Journal of Biological Chemistry|March 11, 2015
Membrane and integrative nuclear fibroblastic growth factor receptor (FGFR) regulation of FGF-23Xiaobin Han, Zhousheng Xiao, L Darryl Quarles
The Journal of Biological Chemistry|August 16, 2015
Membrane and integrative nuclear fibroblastic growth factor receptor (FGFR) regulation of FGF-23Xiaobin Han, Zhousheng Xiao, L Darryl Quarles
Current Medicinal Chemistry|April 1, 2020
Osteoporosis: Mechanism, Molecular Target and Current Status on Drug DevelopmentHanxuan Li, Zhousheng Xiao, L Darryl Quarles, et al.
Journal of Molecular and Cellular Cardiology|November 24, 2019
FGF23 induced left ventricular hypertrophy mediated by FGFR4 signaling in the myocardium is attenuated by soluble Klotho in miceXiaobin Han, Chun Cai, Zhousheng Xiao, et al.
Frontiers in Endocrinology|June 28, 2018
Role of Fibroblast Growth Factor-23 in Innate Immune ResponsesElizabeth A Fitzpatrick, Xiaobin Han, Zhousheng Xiao, et al.
Trends in Pharmacological Sciences|October 1, 2023
Structural asymmetry in FGF23 signalingShih-Hsien Liu, Zhousheng Xiao, Jeremy C Smith, et al.
Plos One|October 3, 2012
Conditional mesenchymal disruption of pkd1 results in osteopenia and polycystic kidney diseaseNi Qiu, Zhousheng Xiao, Li Cao, et al.
Plos One|December 15, 2010
Kif3a deficiency reverses the skeletal abnormalities in Pkd1 deficient mice by restoring the balance between osteogenesis and adipogenesisNi Qiu, Li Cao, Valentin David, et al.
Pageof 5